New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia AstraZeneca h...
Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated financial results ...
The Company has been granted permission from the Indian Central Drugs Standard Control Organization (CDSCO) to conduct its global, pivotal Phase 3 clinical...
“We are thrilled to have established a partnership with Dr. Reddy’s while toripalimab’s global commercial network has been steadily expan...
A study conducted by the Indian Council of Medical Research (ICMR) in collaboration with the Ministry of Health and Family Welfare, Government of India, wh...
Largely driven by increasing incidence of chronic and infectious diseases and growth in biotechnology and pharma industries, the global immunoassay market ...
All India Institute of Medical Sciences (AIIMS) New Delhi and India Medtronic, a wholly owned subsidiary of Ireland-based Medtronic plc, has announced the ...
Corning Incorporated announced the launch of its Advanced Flow Pharmaceutical Technology (AFPT) services business to help contract development m...
Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced the o...
"Receiving FDA approval on our HPAPI fill line is an exciting milestone for our company, and couldn't have happened without the hard work, hours of prepara...
Takeda Biopharmaceuticals India Private Limited Showcased Digital Innovations- MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting ·...
“Women are looking at the food supply with different eyes. Women see every ingredient as food that will nourish the family, and this is vastly differ...
Cancer is one of the leading causes of death across Asian countries. According to a report published by Janssen Asia Pacific, in 2017, overall, there wer...
Interim report of the safety and immunogenicity endpoints from the Phase II/III study has been submitted to the Drug Controller General of India (DCGI) f...
© 2025 Biopharma Boardroom. All Rights Reserved.
